MedTrace Logo

Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery

NCT01199510 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-11-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of FID 112903 (SYSTANE ULTRA® Lubricating Drops) plus standard of care to standard of care alone, in subjects with a history of intermittent eye irritation or dryness related to environmental factors and scheduled for routine cataract surgery.

Conditions

  • Dry Eye
  • Cataract Surgery

Interventions

OTHER

FID 112903 (SYSTANE® ULTRA Lubricant Eye Drops) plus standard of care

Patients will dose 4 times daily for 30 days with FID 112903 and follow routine standard of care post-operatively

OTHER

Standard of Care

Post Cataract Surgery Standard of Care

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-06-30
Completion
2011-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01199510 on ClinicalTrials.gov